TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1873423

Group type: EXPERIMENTAL
Intervention: Dehydrobenzperidol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dipotassium chlorazepate
Number of subjects: 0
Study: 7115656

Group type: EXPERIMENTAL
Intervention: Iron-folic acid supplements (20 mg elemental Fe and 0.1 mg folic acid daily for 60 days)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Iron-folic acid supplements (40 mg Fe and 0.2 mg folic acid daily in two divided doses for 60 days)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sugar placebos
Number of subjects: 14
Study: 31520679

Group type: EXPERIMENTAL
Intervention: African ancestry greater than the median (≥82%) in black subjects
Number of subjects: 1840

Group type: EXPERIMENTAL
Intervention: Common risk factors for exacerbations (history of 2 or more exacerbations in the previous year and FEV1 percent predicted values)
Number of subjects: 1840

Group type: EXPERIMENTAL
Intervention: Chronic sinusitis, allergic rhinitis, and gastroesophageal reflux disease
Number of subjects: 1840

Group type: COMPARATOR
Intervention: Race and percentage of genetic African ancestry as continuous variable
Number of subjects: 1840
Study: 31272709

Group type: EXPERIMENTAL
Intervention: Fruquintinib 4 mg in fed state
Number of subjects: 29

Group type: COMPARATOR
Intervention: Fruquintinib in fasted state
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Fruquintinib in fed state
Number of subjects: 29
Study: 28328324

Group type: EXPERIMENTAL
Intervention: Pregabalin (150 mg per day adjusted to a maximum of 600 mg per day)
Number of subjects: 209

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 209
Study: 26321593

Group type: EXPERIMENTAL
Intervention: Inhaled epinephrine
Number of subjects: 404

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 404
Study: 23240927

Group type: EXPERIMENTAL
Intervention: Home visits for advising mothers about breastfeeding and weaning
Number of subjects: 500

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 500
Study: 21785479

Group type: EXPERIMENTAL
Intervention: 5 mg triamcinolone
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: 10 mg triamcinolone
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: 20 mg triamcinolone
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: 40 mg triamcinolone
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 160
Study: 20048485

Group type: EXPERIMENTAL
Intervention: Acute exercise (45-minute duration, 65% heart rate reserve)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (no acute exercise)
Number of subjects: 16
Study: 16112241

Group type: EXPERIMENTAL
Intervention: Insulin glargine (LANTUS) at bedtime plus previous oral hypoglycaemic agents (OHAs)
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Insulin glargine (LANTUS)
Number of subjects: 239
Study: 15515744

Group type: EXPERIMENTAL
Intervention: GIK‐201Tl SPECT
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 18F‐FDG‐PET
Number of subjects: 21

Group type: COMPARATOR
Intervention: resting‐201Tl imaging
Number of subjects: 21
Study: 11246842

Group type: EXPERIMENTAL
Intervention: Physical activity expended on recreational activities and stair climbing (< 840, 840‐2519, 2520‐6299, > or = 6300 kJ/week)
Number of subjects: 39322

Group type: EXPERIMENTAL
Intervention: Physical activity expended on recreational activities and stair climbing among postmenopausal women
Number of subjects: 39322

Group type: EXPERIMENTAL
Intervention: Vigorous recreational activity requiring > or = 6 METs
Number of subjects: 39322

Group type: EXPERIMENTAL
Intervention: Physical activity
Number of subjects: 39322
Study: 10680508

Group type: EXPERIMENTAL
Intervention: Displacement of nasal cartilages
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Hypoplasia of nasal cartilages
Number of subjects: 38
Study: 7525240

Group type: EXPERIMENTAL
Intervention: SNCV of P3 (third palmar branch)
Number of subjects: 62

Group type: COMPARATOR
Intervention: SNCV of P2 (second palmar branch)
Number of subjects: 62

Group type: COMPARATOR
Intervention: SNCV of M4 (ring finger)
Number of subjects: 62
Study: 3298136

Group type: EXPERIMENTAL
Intervention: Interferon alfa-2b (Intron A; Schering-Plough)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Busulfan (induction therapy)
Number of subjects: 14
Study: 29688834

Group type: EXPERIMENTAL
Intervention: My Changed Body (MyCB) intervention
Number of subjects: 304

Group type: COMPARATOR
Intervention: Expressive writing control arm
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: MyCB intervention
Number of subjects: 304
Study: 27859619

Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE‐A)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Client-Centered Therapy (CCT)
Number of subjects: 61
Study: 24692613

Group type: EXPERIMENTAL
Intervention: Electrocautery of the patellar rim
Number of subjects: 300

Group type: COMPARATOR
Intervention: No electrocautery of the patellar rim
Number of subjects: 300
Study: 23034724

Group type: EXPERIMENTAL
Intervention: Waist Circumference (WC)
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Waist-Hip Ratio (WHR)
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Sagittal Abdominal Diameter (SAD)
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Waist-Height Ratio (WHtR)
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Waist Circumference (WC) in males
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Waist-Hip Ratio (WHR) in males
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Sagittal Abdominal Diameter (SAD) in males
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Waist-Height Ratio (WHtR) in males
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Measures of abdominal obesity in females
Number of subjects: 237
Study: 21111273

Group type: EXPERIMENTAL
Intervention: PCDV (Portable Oxygen Concentrator with Demand Valve)
Number of subjects: 19

Group type: COMPARATOR
Intervention: O(2)Liq (Liquid Oxygen by Continuous Flow)
Number of subjects: 19
Study: 18209510

Group type: EXPERIMENTAL
Intervention: Bromocriptine (5 mg twice a day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 17016190

Group type: EXPERIMENTAL
Intervention: Single-injection volar subcutaneous block
Number of subjects: 27

Group type: COMPARATOR
Intervention: Two-injection dorsal block
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Preference for volar block
Number of subjects: 27
Study: 14530478

Group type: EXPERIMENTAL
Intervention: Combined prone and supine acquisitions
Number of subjects: 3834

Group type: COMPARATOR
Intervention: Supine-only imaging
Number of subjects: 3834
Study: 11012470

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg or Lansoprazole 30 mg taken 15 min before breakfast
Number of subjects: 21

Group type: COMPARATOR
Intervention: Omeprazole 20 mg or Lansoprazole 30 mg taken without a meal
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Omeprazole or Lansoprazole taken with breakfast (after removing the 1 h breakfast period)
Number of subjects: 21
Study: 8975939

Group type: EXPERIMENTAL
Intervention: UFT (300 mg/day) from 5th postoperative week for one year
Number of subjects: 101

Group type: COMPARATOR
Intervention: Epirubicin (40 mg/m2) bolus injection arterially on day 28, in addition to UFT administration
Number of subjects: 101
Study: 1335638

Group type: EXPERIMENTAL
Intervention: Group A (CLF strain, 360 ELISA units, 0.5 mg aluminium hydroxide)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Group B (HM175 strain, 180 ELISA units, 1 mg aluminium hydroxide)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Group C (HM175 strain, 360 ELISA units, 0.5 mg aluminium hydroxide)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Group D (HM175 strain, 360 ELISA units, 1 mg aluminium hydroxide)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Group E (HM175 strain, 720 ELISA units, 1 mg aluminium hydroxide)
Number of subjects: 199
Study: 380631

Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Doxycycline (first treatment)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Overall treatment effect
Number of subjects: 42
Study: 30791557

Group type: EXPERIMENTAL
Intervention: 12 g of Polydextrose per day
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: 8 g of Polydextrose per day
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: 4 g of Polydextrose per day
Number of subjects: 192

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 192
Study: 27830395

Group type: EXPERIMENTAL
Intervention: Glutamine (6 g/m2 per dose twice daily, maximum 10 g/dose)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 25611116

Group type: EXPERIMENTAL
Intervention: Mental health intervention (PROTECT)
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Mental health screening
Number of subjects: 315
Study: 23937753

Group type: EXPERIMENTAL
Intervention: Nonoperative treatment
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Operative treatment
Number of subjects: 80
Study: 21909490

Group type: EXPERIMENTAL
Intervention: Closed-tray technique
Number of subjects: 7

Group type: COMPARATOR
Intervention: Open-tray technique
Number of subjects: 7
Study: 19824413

Group type: EXPERIMENTAL
Intervention: Ketofol (ketamine/propofol ratio of 1:4)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Ketofol (higher mass fraction of ketamine)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Ketofol (general use)
Number of subjects: 152
Study: 17109504

Group type: EXPERIMENTAL
Intervention: Continuous Accelerated Irradiation (CAIR)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional Irradiation (CR)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups (CAIR and CR)
Number of subjects: 60
Study: 15924620

Group type: EXPERIMENTAL
Intervention: High-intensity exercise program (twice weekly, one hour sessions for six weeks, performed at >= 60% of maximum heart rate)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (non-intervention)
Number of subjects: 61
Study: 12511367

Group type: EXPERIMENTAL
Intervention: IOP reduction achieved by medical, laser, or surgical therapy in OAG patients
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: IOP reduction achieved by medical, laser, or surgical therapy in OHT patients
Number of subjects: 40
Study: 10543286

Group type: EXPERIMENTAL
Intervention: Formoterol (12 microg) + Beclomethasone (500 microg x day(‐1))
Number of subjects: 132

Group type: COMPARATOR
Intervention: Beclomethasone (1000 microg x day(‐1))
Number of subjects: 132
Study: 7542972

Group type: EXPERIMENTAL
Intervention: TULIP (transurethral ultrasound-guided laser-induced prostatectomy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: TURP (transurethral resection of the prostate)
Number of subjects: 0
Study: 1708961

Group type: EXPERIMENTAL
Intervention: Early suckling (treatment group)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (delayed contact)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Both groups (breastfeeding prior to temperature recording)
Number of subjects: 160
Study: 373903

Group type: EXPERIMENTAL
Intervention: Mefloquine (1.5 g)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Pyrimethamine (75 mg) plus sulfadoxine (1.5 g)
Number of subjects: 75
Study: 31991214

Group type: EXPERIMENTAL
Intervention: Clindamycin
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Rifampicin
Number of subjects: 54

Group type: COMPARATOR
Intervention: Sterile saline
Number of subjects: 54
Study: 29566128

Group type: EXPERIMENTAL
Intervention: Evolocumab (420 mg every 2 weeks)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Evolocumab (monotherapy)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Evolocumab (in combination with atorvastatin)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Evolocumab and atorvastatin (substudy of 16 subjects)
Number of subjects: 63
Study: 28303624

Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 2587

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2587
Study: 25754148

Group type: EXPERIMENTAL
Intervention: Potato soup with MSG (5% w/w)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Potato soup without MSG
Number of subjects: 40
Study: 24035299

Group type: EXPERIMENTAL
Intervention: Controlled temporary phrenic nerve palsy induced by local administration of lidocaine 1% at a rate of 3 mL/h (30 mg/h) via catheter.
Number of subjects: 10

Group type: COMPARATOR
Intervention: No induced phrenic nerve palsy (normal function).
Number of subjects: 10
Study: 21406489

Group type: EXPERIMENTAL
Intervention: Diabetes Intensive Education Program (DIEP)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 50
Study: 18230022

Group type: EXPERIMENTAL
Intervention: Social-evaluative threat (SET) condition
Number of subjects: 89

Group type: COMPARATOR
Intervention: Presence of inattentive confederate (PRES) condition
Number of subjects: 89

Group type: COMPARATOR
Intervention: Alone in a room (non-SET) condition
Number of subjects: 89
Study: 16174016

Group type: EXPERIMENTAL
Intervention: Cryoablation at -70 degrees C
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Cryomapping at -30 degrees C
Number of subjects: 32

Group type: COMPARATOR
Intervention: Radiofrequency (RF) current application
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Cryoablation
Number of subjects: 32
Study: 12768300

Group type: EXPERIMENTAL
Intervention: Metformin (850 mg, two times per day)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: GnRH analogue (goserelin 3.6 mg, every 28 days)
Number of subjects: 50
Study: 10376918

Group type: EXPERIMENTAL
Intervention: edrophonium HCl (12 to 18 mg)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control (no drug)
Number of subjects: 28
Study: 9091852

Group type: EXPERIMENTAL
Intervention: Water immersion (WI) for 2 hours
Number of subjects: 18
Study: 2066823

Group type: EXPERIMENTAL
Intervention: Poster intervention group (weekly tracking with poster)
Number of subjects: 4772

Group type: EXPERIMENTAL
Intervention: Poster/postcard intervention group (weekly tracking with poster and postcard reminders)
Number of subjects: 4772

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 4772
Study: 6799196

Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition (TPN) during ProMACE-MOPP treatment
Number of subjects: 74

Group type: COMPARATOR
Intervention: Standard diet during ProMACE-MOPP treatment
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition (TPN) as an adjunct to chemotherapy or chemotherapy plus total body irradiation
Number of subjects: 74

Group type: COMPARATOR
Intervention: Standard diet as an adjunct to chemotherapy or chemotherapy plus total body irradiation
Number of subjects: 74
Study: 31941354

Group type: COMPARATOR
Intervention: Intravenous Amiodarone
Number of subjects: 3019

Group type: COMPARATOR
Intervention: Intravenous Lidocaine
Number of subjects: 3019

Group type: COMPARATOR
Intervention: Intraosseous Amiodarone
Number of subjects: 3019

Group type: COMPARATOR
Intervention: Intraosseous Lidocaine
Number of subjects: 3019

Group type: COMPARATOR
Intervention: Intravenous Drugs (Amiodarone or Lidocaine)
Number of subjects: 3019

Group type: COMPARATOR
Intervention: Intraosseous Drugs (Amiodarone or Lidocaine)
Number of subjects: 3019

Group type: COMPARATOR
Intervention: Placebo (Intravenous and Intraosseous)
Number of subjects: 3019
Study: 30883877

Group type: EXPERIMENTAL
Intervention: 0.1% adapalene gel
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0.025% tretinoin cream
Number of subjects: 0
Study: 29223956

Group type: EXPERIMENTAL
Intervention: Statin treatment
Number of subjects: 9423

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9423
Study: 26226999

Group type: EXPERIMENTAL
Intervention: Ranolazine 750 mg BID and Dronedarone 225 mg BID
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Ranolazine 750 mg BID and Dronedarone 150 mg BID
Number of subjects: 134

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134

Group type: COMPARATOR
Intervention: Ranolazine alone (750 mg BID)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Dronedarone alone (225 mg BID)
Number of subjects: 134
Study: 24512944

Group type: EXPERIMENTAL
Intervention: brief motivational phone intervention (pBMI)
Number of subjects: 57

Group type: COMPARATOR
Intervention: assessment only
Number of subjects: 57
Study: 22113931

Group type: EXPERIMENTAL
Intervention: Monitored anaesthesia care (MAC) with paracervical local anaesthesia and remifentanil
Number of subjects: 91

Group type: COMPARATOR
Intervention: Total intravenous anaesthesia (TIVA) with propofol and remifentanil
Number of subjects: 91
Study: 19208440

Group type: EXPERIMENTAL
Intervention: Sodium valproate and GTN spray (group A)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo drug and GTN spray (group B)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Sodium valproate and placebo spray (group C)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo drug and placebo spray (group D)
Number of subjects: 83
Study: 17890876

Group type: EXPERIMENTAL
Intervention: Intravenous EPO
Number of subjects: 158
Study: 17163894

Group type: EXPERIMENTAL
Intervention: HIV prevention interventions targeting adolescent girls
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Combination of providing information and behavioral skills training
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Ongoing studies
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Full-scale longitudinal interventions
Number of subjects: 6
Study: 10958127

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Nitroglycerin
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both (diazepam and nitroglycerin)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 40
Study: 9278201

Group type: EXPERIMENTAL
Intervention: Prednisolone (10 mg)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Promethazine (25 mg)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Niacin
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Prednisolone and Niacin combination
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Chloroquine (2.1 g base total dose) with Prednisolone
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: No treatment with Prednisolone
Number of subjects: 28
Study: 8316971

Group type: EXPERIMENTAL
Intervention: Transcervical CVS
Number of subjects: 3079

Group type: EXPERIMENTAL
Intervention: Transabdominal CVS
Number of subjects: 3079

Group type: COMPARATOR
Intervention: Amniocentesis
Number of subjects: 3079
Study: 3105310

Group type: EXPERIMENTAL
Intervention: 200 g of carbohydrate in an isocaloric diet
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 50 g of carbohydrate in an isocaloric diet
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control dietary period
Number of subjects: 8
Study: 29607766

Group type: EXPERIMENTAL
Intervention: FAIS-specific physical therapy group received personalized progressive strengthening and functional retraining.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group received standardized stretching exercises.
Number of subjects: 24
Study: 27052652

Group type: EXPERIMENTAL
Intervention: Pemetrexed plus carboplatin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single-agent pemetrexed
Number of subjects: 0
Study: 24486883

Group type: EXPERIMENTAL
Intervention: LY545694 (25mg twice daily)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Gabapentin (600mg 8 hours apart; 6 doses over 3 days)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 22221173

Group type: EXPERIMENTAL
Intervention: High dose ursodeoxycholic acid (UDCA) at 17-23 mg/kg/day
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: High dose ursodeoxycholic acid (UDCA)
Number of subjects: 98
Study: 20556559

Group type: EXPERIMENTAL
Intervention: Flavocoxid (569 mg HED)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Flavocoxid combined with aspirin (370 mg HED)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Flavocoxid in healthy volunteers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Flavocoxid in previously warfarinized patients
Number of subjects: 0
Study: 18338138

Group type: EXPERIMENTAL
Intervention: Laryngeal tube suction (LTS-D)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Bag-mask ventilation (BMV)
Number of subjects: 50
Study: 16001913

Group type: EXPERIMENTAL
Intervention: Autogenous bone plus resorbable membrane (ABM)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Autogenous iliac bone graft (ABG)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Nonresorbable expanded polytetrafluoroethylene Gore‐Tex TR membrane (GTM)
Number of subjects: 15
Study: 15314950

Group type: EXPERIMENTAL
Intervention: GIK mixture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10475511

Group type: EXPERIMENTAL
Intervention: Washing products containing naturally-derived grit
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Washing products containing synthetic grit
Number of subjects: 16
Study: 7675373

Group type: EXPERIMENTAL
Intervention: specially‐formulated, carbohydrate‐rich beverage
Number of subjects: 24

Group type: COMPARATOR
Intervention: isocaloric placebo interventions
Number of subjects: 24
Study: 2123065

Group type: EXPERIMENTAL
Intervention: Mild induction chemotherapy in patients aged greater than or equal to 70 and/or with concurrent nonhematologic disorders (28 patients)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Conventional induction chemotherapy in eligible patients (52 patients)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Supportive care alone in patients not suitable for induction chemotherapy (23 patients)
Number of subjects: 103
Study: 7382828

Group type: EXPERIMENTAL
Intervention: Phenformin (biguanide)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 30041173

Group type: EXPERIMENTAL
Intervention: Specific dual-task training (walking and counting)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group (unspecific low-intensity exercise)
Number of subjects: 105
Study: 30672195

Group type: EXPERIMENTAL
Intervention: Combined therapy of Hegu needling and Shu needling techniques at the positive reaction points
Number of subjects: 90

Group type: COMPARATOR
Intervention: Conventional acupuncture therapy
Number of subjects: 90